THE TREATMENT OF NEOVASCULAR GLAUCOMA CAUSED BY CENTRAL VEIN OCCLUSION WITH CYCLOCRYOTHERAPY-A CASE REPORT

Q4 Medicine
Muhamedin Rushiti, Irina Bogdanova
{"title":"THE TREATMENT OF NEOVASCULAR GLAUCOMA CAUSED BY CENTRAL VEIN OCCLUSION WITH CYCLOCRYOTHERAPY-A CASE REPORT","authors":"Muhamedin Rushiti, Irina Bogdanova","doi":"10.55302/jms2362109r","DOIUrl":null,"url":null,"abstract":"Glaucoma is the world's number one cause of irreversible blindness. Worldwide, there are over 65 million people diagnosed with various types of glaucoma. According to the latest definitions, it is a neuropathic progressive disease of the optic nerve. The main divisions are primary open and closed angle glaucoma and secondary glaucoma which is caused by various systemic or local diseases. Among the most common types of secondary glaucoma is neovascular glaucoma, which can be caused by diabetic retinopathy, arterial hypertension, various vasculopathies, inflammatory processes of the eye, trauma and other factors. Neovascular glaucoma is a serious and aggressive form of glaucoma that has rapid progression and manifestations. The main symptoms are high eye pressure, pain, redness and the appearance of small vessels in the iris.There are various treatments for this disease, but mainly they are aimed at relieving the symptoms or reducing the progression of the disease. The most important therapeutic options, apart from anti-glaucoma drugs, are the application of anti-Vegf therapy and cyclodestructive treatments, which enable the reduction of intraocular pressure and alleviation of symptoms, thus enabling patients to have a better quality of life.The aim of our study was to prove the impact of cyclocryotherapy in reducing intraocular pressure in a 43-year-old female patient. age with neovascular glaucoma of the left eye. The pressure before the intervention was 41.4 mmHg, while after the intervention it decreased to 26.6 mmHg, also the symptoms such as pain and redness subsided. Key words; Neovascular glaucoma, retinal vein occlusion, cyclo-cryotherapy.","PeriodicalId":16444,"journal":{"name":"Journal of Morphological Sciences","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Morphological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55302/jms2362109r","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Glaucoma is the world's number one cause of irreversible blindness. Worldwide, there are over 65 million people diagnosed with various types of glaucoma. According to the latest definitions, it is a neuropathic progressive disease of the optic nerve. The main divisions are primary open and closed angle glaucoma and secondary glaucoma which is caused by various systemic or local diseases. Among the most common types of secondary glaucoma is neovascular glaucoma, which can be caused by diabetic retinopathy, arterial hypertension, various vasculopathies, inflammatory processes of the eye, trauma and other factors. Neovascular glaucoma is a serious and aggressive form of glaucoma that has rapid progression and manifestations. The main symptoms are high eye pressure, pain, redness and the appearance of small vessels in the iris.There are various treatments for this disease, but mainly they are aimed at relieving the symptoms or reducing the progression of the disease. The most important therapeutic options, apart from anti-glaucoma drugs, are the application of anti-Vegf therapy and cyclodestructive treatments, which enable the reduction of intraocular pressure and alleviation of symptoms, thus enabling patients to have a better quality of life.The aim of our study was to prove the impact of cyclocryotherapy in reducing intraocular pressure in a 43-year-old female patient. age with neovascular glaucoma of the left eye. The pressure before the intervention was 41.4 mmHg, while after the intervention it decreased to 26.6 mmHg, also the symptoms such as pain and redness subsided. Key words; Neovascular glaucoma, retinal vein occlusion, cyclo-cryotherapy.
循环冷冻治疗中央静脉闭塞致新生血管性青光眼1例
青光眼是世界上导致不可逆失明的头号原因。在世界范围内,有超过6500万人被诊断患有各种类型的青光眼。根据最新的定义,它是一种视神经的神经性进行性疾病。主要分为原发性开闭角型青光眼和继发性青光眼,后者是由各种全身或局部疾病引起的。继发性青光眼中最常见的类型是新生血管性青光眼,它可由糖尿病视网膜病变、动脉高血压、各种血管病变、眼睛炎症过程、外伤等因素引起。新生血管性青光眼是一种严重的侵袭性青光眼,具有快速的进展和表现。主要症状是眼压高、疼痛、发红和虹膜出现小血管。这种疾病有多种治疗方法,但主要是为了缓解症状或减缓疾病的进展。除抗青光眼药物外,最重要的治疗选择是应用抗vegf疗法和破坏睫状体的治疗,这可以降低眼压,减轻症状,从而使患者有更好的生活质量。我们研究的目的是证明循环冷冻治疗对降低43岁女性患者眼压的影响。年龄伴左眼新生血管性青光眼。干预前血压为41.4 mmHg,干预后血压降至26.6 mmHg,疼痛、红肿等症状也有所缓解。关键字;新生血管性青光眼,视网膜静脉闭塞,循环冷冻治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信